Trial intelligence / Profile preview

Oral Immunotherapy for Wheat Allergy

NCT01980992Phase 2Completed

Start
Oct 2013
Primary completion
Nov 2015
Countries
1
01

Overview

A Phase 2 trial of vital wheat gluten in wheat allergy. Started Oct 2013; status: completed.

02

Drugs

vital wheat gluten
03

Conditions

wheat allergy

Beyond the preview

Go deeper on NCT01980992.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01980992.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call